Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Ceramides Promote Viral Replication via Autophagy in RGNNV I
2026-07-05
This study leverages global lipidomics to demonstrate that ceramides are crucial pro-viral mediators in red-spotted grouper nervous necrosis virus (RGNNV) infection. By elucidating the mechanistic link between ceramide metabolism and autophagy, the research suggests new avenues for antiviral strategies in aquaculture.
-
Troglitazone: Applied PPARγ Agonist Workflows in Tumor and M
2026-07-04
Troglitazone is a dual PPARγ/α agonist empowering both type 2 diabetes and anti-tumor studies through precise modulation of nuclear receptor pathways. This article delivers protocol-driven, literature-backed strategies and troubleshooting tips for maximizing reproducibility and biological insight using APExBIO’s high-purity troglitazone.
-
EdU Imaging Kits (488): Reliable S-Phase DNA Synthesis Detec
2026-07-03
EdU Imaging Kits (488) enable sensitive, DNA synthesis-specific cell proliferation assays using 5-ethynyl-2'-deoxyuridine and click chemistry. These kits outperform traditional BrdU assays by preserving cell integrity and improving workflow efficiency. Their validated performance supports advanced applications in research and diagnostics.
-
FGFR4-Variant CRC Organoids Advance Drug Sensitivity Profili
2026-07-03
This study pioneers the use of patient-derived colorectal cancer organoids with FGFR4 variants and wild-type genotypes to directly compare responses to targeted and chemotherapeutic agents. The findings highlight the non-selective efficacy of FGFR4 inhibitors and elucidate key downstream signaling pathways involved in tumor suppression.
-
TTP Modulates m6A-Dependent TGF-β1 mRNA Stability in Liver F
2026-07-02
This study uncovers a novel mechanism by which tristetraprolin (TTP) mitigates schistosomiasis-induced liver fibrosis through m6A-mediated destabilization of TGF-β1 mRNA. The findings provide a foundation for targeting epitranscriptomic regulation in hepatic fibrosis and highlight new directions for methylation-focused research.
-
Y-27632 dihydrochloride: Optimizing ROCK Inhibition in Cance
2026-07-02
Y-27632 dihydrochloride, a highly selective ROCK inhibitor, empowers researchers with reproducible modulation of cytoskeletal dynamics and tumor invasion. Learn how protocol-driven workflows and troubleshooting strategies unlock its full potential in translational cancer and stem cell biology.
-
Captopril and Bradykinin: Unraveling ACE Inhibition Beyond B
2026-07-01
Explore how Captopril, a potent ACE inhibitor, influences both hypertension and gastrointestinal peristalsis via bradykinin modulation. This article offers a deep dive into novel mechanistic insights and advanced applications for researchers.
-
Transmission Dynamics of Carbapenemase Genes in CREC in Guan
2026-07-01
This study provides an in-depth molecular characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China. Through plasmid profiling, conjugation assays, and genotyping, the research reveals high prevalence and transfer efficiency of blaNDM-1 and related genes, highlighting urgent challenges for antimicrobial stewardship and Gram-negative infection research.
-
Nilotinib (AMN-107): Unlocking BCR-ABL and Ribosomal Stress
2026-06-30
This thought-leadership article explores the dual frontier of kinase signaling and ribosomal stress in translational cancer research, positioning Nilotinib (AMN-107) as both a precision tool and strategic asset. We integrate mechanistic insights from the latest studies on ribotoxic stress and BCR-ABL pathway inhibition, offer protocol guidance, and delineate actionable opportunities for researchers driving innovation beyond established paradigms.
-
EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Engineering Extrahepatic Imm
2026-06-30
Explore how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) enables precise, extrahepatic immune modulation through advanced mRNA engineering and biomimetic delivery. This article delivers a deeper mechanistic analysis for translational immunotherapy applications.
-
Ribonuclease R (20 U/μL): Redefining Circular RNA Validation
2026-06-29
Explore how Ribonuclease R (20 U/μL) revolutionizes circular RNA validation and DNA damage pathway studies. This article reveals advanced assay strategies, bridges circRNA biology with inflammation mechanisms, and provides expert protocol guidance for next-generation RNA research.
-
TBK1 Inhibition Alleviates Diabetic Neuropathy via Microglia
2026-06-29
Liao et al. uncover that TANK-binding kinase 1 (TBK1) drives painful diabetic neuropathy (PDN) by promoting microglial pyroptosis. Their mechanistic work demonstrates that TBK1 inhibition—either genetically or pharmacologically—reduces neuropathic pain and supports new therapeutic strategies for PDN.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Elevating Mouse IgG
2026-06-28
The Cy3 Goat Anti-Mouse IgG (H+L) Antibody delivers high-sensitivity mouse IgG detection, transforming immunofluorescence and proteomics workflows. Its robust signal amplification and reliable performance empower biomarker discovery in complex disease models and translational research.
-
PDHA1 Succinylation Mediates Immune Evasion in Cholangiocarc
2026-06-27
The referenced study uncovers how succinylation of PDHA1 at lysine 83 in cholangiocarcinoma cells drives metabolic reprogramming, resulting in alpha-ketoglutaric acid accumulation and suppressed macrophage antigen presentation. These findings illuminate a key metabolic-immune axis in tumor progression and suggest new strategies for sensitizing cholangiocarcinoma to chemotherapy.
-
Exo1 (SKU B6876): Reliable Exocytic Pathway Inhibition for C
2026-06-26
This article addresses the practical challenges of membrane trafficking inhibition and exocytosis assays in biomedical research, highlighting how Exo1 (SKU B6876) offers reliable, mechanism-specific solutions. Drawing on recent literature and quantitative data, it demonstrates where Exo1’s unique mode of action enhances reproducibility and interpretability in complex cellular workflows.